IE841484L - 13-alpha-alkyl-gonanes - Google Patents
13-alpha-alkyl-gonanesInfo
- Publication number
- IE841484L IE841484L IE841484A IE148484A IE841484L IE 841484 L IE841484 L IE 841484L IE 841484 A IE841484 A IE 841484A IE 148484 A IE148484 A IE 148484A IE 841484 L IE841484 L IE 841484L
- Authority
- IE
- Ireland
- Prior art keywords
- carbon atoms
- alkyl
- hydrogen
- alpha
- beta
- Prior art date
Links
- 125000004432 carbon atom Chemical group C* 0.000 abstract 12
- 125000000217 alkyl group Chemical group 0.000 abstract 10
- 229910052739 hydrogen Inorganic materials 0.000 abstract 10
- 239000001257 hydrogen Substances 0.000 abstract 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 4
- 150000002431 hydrogen Chemical class 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract 2
- 150000001204 N-oxides Chemical group 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 125000004423 acyloxy group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000001589 carboacyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- -1 methoxyphenyl Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 150000003431 steroids Chemical group 0.000 abstract 2
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 125000005853 β-dimethylaminoethyl group Chemical group 0.000 abstract 2
- 125000004825 2,2-dimethylpropylene group Chemical group [H]C([H])([H])C(C([H])([H])[H])(C([H])([H])[*:1])C([H])([H])[*:2] 0.000 abstract 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 238000005935 nucleophilic addition reaction Methods 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
1. Claims for the Contracting States BE, CH, LI, DE, FR, GB, IT, LU, NL, SE 13 alpha-Alkyl gonanes of general formula I see diagramm : EP0129499,P14,F3 wherein R**1 means -N R**II -R**I wherein R**I and R**II are hydrogen or alkyl of 1-4 carbon atoms, or R**I and R**II with inclusion of N mean a saturated 5- or 6-membered ring, wherein the ring can contain, besides N, still another hetero atom, such as O, N, S, as well as the corresponding tertiary N-oxides and the acid addition salts, OR**III wherein R**III means methyl, ethyl, propyl, methoxyphenyl, allyl, or beta-dimethylaminoethyl, R**2 means a hydrogen atom, a methyl group or an ethyl group, R**3 means -(CH2 )n -CH3 with n=0-4, -(CH2 )n -CH2 -O(S)R**IV with n=0-4, and R**IV meaning hydrogen or alkyl of 1-4 carbon atoms, -CH=CH-(CH2 )n -OR**V with n=1-4, and R**V meaning hydrogen, alkyl, or alkanoyl of respectively 1-4 carbon atoms, -C -= C-X wherein X means hydrogen, alkyl of 1-4 carbon atoms, or halogen, -(CH2 )n -CH2 CN with n=0-3 or see diagramm : EP0129499,P14,F4 wherein Y means hydrogen or OR**V , R**4 is hydroxy, alkoxy, or alkanoyloxy of respectively 1-4 carbon atoms or R**3 /R**4 means see diagramm : EP0129499,P14,F2 wherein R**3 is in the alpha-position and R**4 is in the beta-position, or R**3 is in the beta-position and R**4 is in the alpha-position with respect to the steroid skeleton, and R**5 is a hydrogen atom or an alpha- or beta-positioned alkyl group of 1-4 carbon atoms. 1. Claim for the Contracting State AT Process for the preparation of 13 alpha-alkylgonanes of the general formula I see diagramm : EP0129499,P15,F4 wherein R**1 represents -N R**II -R**I , wherein R**I and R**II represent hydrogen or alkyl having from 1 to 4 carbon atoms, or R**I and R**II , with the inclusion of N, represent a saturated 5- or 6-membered ring, wherein the ring can contain, in addition to N, a further hetero atom, such as O, N or S, as well as the corresponding tertiary N-oxides and the acid addition salts, or represents -OR**III , wherein R**III represents methyl, ethyl, propyl, methoxyphenyl, allyl or beta-dimethylaminoethyl, R**2 represents a hydrogen atom, a methyl group or an ethyl group, R**3 represents -(CH2 )n -CH3 , where n=0-4, -(CH2 )n -CH2 -O(S)R**IV , where n=0-4 and R**IV represents hydrogen or alkyl having from 1 to 4 carbon atoms, -CH=CH-(CH2 )n -OR**V , where n=1-4 and R**V represents hydrogen, alkyl or alkanoyl each having from 1 to 4 carbon atoms, -C -= C-X, where X represents hydrogen, alkyl having from 1 to 4 carbon atoms, or halogen, -(CH2 )n -CH2 CN, where n=0-3, or see diagramm : EP0129499,P15,F7 where Y represents hydrogen or OR**V , where R**V has the meanings given above, R**4 represents hydroxy, alkoxy or alkanoyloxy each having from 1 to 4 carbon atoms, or R**3 /R**4 represents see diagramm : EP0129499,P16,F1 wherein R**3 is in the alpha-position and R**4 is in the beta-position, or R**3 is in the beta-position and R**4 is in the alpha-position with respect to the steroid skeleton, and R**5 represents a hydrogen atom or an alkyl group in the alpha- or beta-position having from 1 to 4 carbon atoms, characterised in that a compound of the general formula II see diagramm : EP0129499,P16,F3 wherein R**1 , R**2 and R**5 have the meanings given in formula I and Z is an ethylene or 2,2-dimethylpropylene group, is irradiated with ultraviolet light, and the 13-episteroid, obtained by UV irradiation, of the general formula III see diagramm : EP0129499,P16,F2 wherein R**1 , R**2 , R**5 and Z have the meanings given in formula II, is converted into the compounds of the general formula I in accordance with methods known per se by nucleophilic addition to the 17-ketone, cleavage of the 3-ketal protective group, and splitting off of water from the 4,5-position.
[EP0129499A2]
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3321826A DE3321826A1 (en) | 1983-06-15 | 1983-06-15 | 13 alpha -Alkylgonanes, the preparation thereof and pharmaceutical products containing these |
| DE19843413036 DE3413036A1 (en) | 1984-04-04 | 1984-04-04 | 13a-Alkylgonanes, the preparation thereof and pharmaceutical products containing these |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE841484L true IE841484L (en) | 1984-12-15 |
| IE57620B1 IE57620B1 (en) | 1993-02-10 |
Family
ID=25811539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1484/84A IE57620B1 (en) | 1983-06-15 | 1984-06-14 | 13alpha-alkylgonanes,their preparation and pharmaceutical preparations containing them |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0129499B1 (en) |
| JP (1) | JPH02167296A (en) |
| AU (1) | AU572849B2 (en) |
| CA (1) | CA1307784C (en) |
| DD (1) | DD218624A5 (en) |
| DE (1) | DE3468030D1 (en) |
| DK (1) | DK166729B1 (en) |
| ES (1) | ES8502612A1 (en) |
| FI (1) | FI78709C (en) |
| GR (1) | GR82210B (en) |
| HU (1) | HU191131B (en) |
| IE (1) | IE57620B1 (en) |
| IL (1) | IL72085A (en) |
| NO (1) | NO160521C (en) |
| NZ (1) | NZ208441A (en) |
| PT (1) | PT78732B (en) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3446661A1 (en) * | 1984-12-18 | 1986-06-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | NEW 13 (ALPHA) -ALKYL-17 (BETA) - (3-ACYLOXYPROPYL) GONANA |
| DE3506785A1 (en) * | 1985-02-22 | 1986-08-28 | Schering AG, Berlin und Bergkamen, 1000 Berlin | 11SS-N, N-DIMETHYLAMINOPHENYL ESTRADIENE, THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM |
| DE3630030A1 (en) * | 1986-09-01 | 1988-03-03 | Schering Ag | 13 (ALPHA) -ALKYLGONAN- (DELTA) (UP ARROW) 9 (UP ARROW) (UP ARROW) ((UP ARROW) (UP ARROW) 1 (UP ARROW) 1 (UP ARROW)) (UP ARROW) -5, 10-EPOXIDE |
| US4774236A (en) * | 1986-09-17 | 1988-09-27 | Research Triangle Institute | 17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them |
| IE60780B1 (en) * | 1987-01-23 | 1994-08-10 | Akzo Nv | New 11-aryl steroid derivatives |
| EP0310542B1 (en) * | 1987-10-01 | 1994-06-08 | Schering Aktiengesellschaft | Antigestagenic and antioestrogenic compounds for the treatment of hormone-dependent tumours |
| JP2785023B2 (en) * | 1987-12-30 | 1998-08-13 | ルセル―ユクラフ | Novel derivative of 17β-OH-19-norsteroid substituted at 17α position, process for its preparation, its use as drug and pharmaceutical composition containing it |
| US4954490A (en) * | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
| DE3822770A1 (en) * | 1988-07-01 | 1990-01-04 | Schering Ag | 13-ALKYL-11SS-PHENYLGONANE |
| DE3832303A1 (en) * | 1988-09-20 | 1990-04-12 | Schering Ag | 11SS-PHENYL-14SSH STEROIDS |
| US5372996A (en) * | 1989-03-10 | 1994-12-13 | Endorecherche, Inc. | Method of treatment of androgen-related diseases |
| US5364847A (en) * | 1989-03-10 | 1994-11-15 | Endorecherche | Inhibitors of sex steroid biosynthesis and methods for their production and use |
| JP2959839B2 (en) * | 1989-07-07 | 1999-10-06 | アンドルシェルシュ・インコーポレイテッド | Androgen derivatives for use in inhibiting sex steroid activity |
| DK0595796T3 (en) * | 1989-07-07 | 2003-05-05 | Endorech Inc | Method of treating androgen-related diseases |
| DK0411733T3 (en) * | 1989-08-04 | 1999-06-28 | Schering Ag | 11-beta-aryl-gona-4,9-dien-3-ones |
| FR2654337B1 (en) * | 1989-11-15 | 1994-08-05 | Roussel Uclaf | NOVEL BIODEGRADABLE INJECTABLE MICROSPHERES PREPARATION METHOD AND INJECTABLE SUSPENSIONS CONTAINING THEM. |
| DE4008584A1 (en) * | 1990-03-15 | 1991-09-26 | Schering Ag | METHOD FOR PRODUCING INTERMEDIATE PRODUCTS FOR THE ANTIGESTAGE SYNTHESIS (ONAPRISTONE SYNTHESIS) |
| US5407928A (en) * | 1990-08-15 | 1995-04-18 | Schering Aktiengesellschaft | 11β-aryl-gona-4,9-dien-3-ones |
| US5472854A (en) * | 1990-08-18 | 1995-12-05 | Schering Aktiengesellschaft | Process for the production of 17-oxosteroids via the fermentative oxidation of 17β-hydroxysteroids by Mycobacterium |
| DE59108700D1 (en) * | 1990-08-18 | 1997-06-12 | Schering Ag | METHOD FOR PRODUCING 17-OXOSTEROIDS |
| MX9301121A (en) * | 1992-03-02 | 1993-09-01 | Schering Ag | METHOD AND EQUIPMENT FOR ORAL CONTRACEPTION AND REGULATION OF MENSTRUATION WITH ESTROGEN / PROGESTIN / ANIPROGESTIN. |
| US7704983B1 (en) | 1992-03-02 | 2010-04-27 | Eastern Virginia Medical School | Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception |
| US5439913A (en) | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| KR950701527A (en) * | 1992-05-21 | 1995-04-28 | 라브리 페르낭 | INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY |
| DE4413185A1 (en) * | 1994-04-12 | 1995-10-19 | Schering Ag | 11beta, 19-bridged 13alpha alkyl steroids |
| DE4415590A1 (en) * | 1994-04-28 | 1995-11-02 | Schering Ag | Process for the stereoselective introduction of an alkynyl side chain to 11β-aryl-substituted 13alpha-alkylgonan-17-ones |
| DE4434488A1 (en) | 1994-09-14 | 1996-03-21 | Schering Ag | Steroid esters and amides, processes for their preparation and their pharmaceutical use |
| ZA9510926B (en) | 1994-12-23 | 1996-07-03 | Schering Ag | Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception |
| RU2129125C1 (en) * | 1995-04-06 | 1999-04-20 | Украинский научно-исследовательский институт фармакотерапии эндокринных заболеваний | METHOD OF SYNTHESIS OF 13α-TRIENE-19-NORANDROSTANE-3-OL-17-ONE AND ITS METHYL ESTER |
| US6900193B1 (en) | 1996-05-01 | 2005-05-31 | The United States Of America As Represented By The Department Of Health And Human Services | Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| ES2152671T3 (en) | 1996-05-01 | 2001-02-01 | Us Gov Health & Human Serv | PROGESTERONE DERIVATIVES REPLACED IN POSITION 21 AS NEW ANTIPROGESTATIONAL AGENTS. |
| US6262042B1 (en) * | 1998-05-29 | 2001-07-17 | Research Triangle Institute | 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| RU2017112748A (en) | 2014-11-17 | 2018-12-19 | Арно Терапьютикс, Инк. | ONAPRISTON COMPOSITIONS OF LONG-TERM ACTIONS AND METHODS |
| AU2016326657B2 (en) * | 2015-09-25 | 2019-10-24 | Context Biopharma, Inc. | Methods of making onapristone intermediates |
| HK1255104A1 (en) * | 2015-12-15 | 2019-08-02 | Context Biopharma Inc. | Amorphous onapristone compositions and methods of making the same |
| WO2018102369A1 (en) | 2016-11-30 | 2018-06-07 | Arno Therapeutics, Inc. | Methods for onapristone synthesis dehydration and deprotection |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2377418A1 (en) * | 1977-01-13 | 1978-08-11 | Roussel Uclaf | NEW 4,9-DIENIC 11B-SUBSTITUTE STEROID DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICINAL PRODUCTS |
| ZA8231B (en) * | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
| DE3347126A1 (en) * | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | 11SS-ARYL-ESTRADIENE, THEIR PRODUCTION AND THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM |
| CA1304916C (en) * | 1984-10-18 | 1992-07-14 | Wilhelm Bannwarth | Apparatus for the parallel performance of a plurality of chemical reaction sequences |
-
1984
- 1984-06-08 ES ES533260A patent/ES8502612A1/en not_active Expired
- 1984-06-12 DK DK288184A patent/DK166729B1/en not_active IP Right Cessation
- 1984-06-13 FI FI842395A patent/FI78709C/en not_active IP Right Cessation
- 1984-06-13 EP EP84730062A patent/EP0129499B1/en not_active Expired
- 1984-06-13 IL IL72085A patent/IL72085A/en not_active IP Right Cessation
- 1984-06-13 GR GR75001A patent/GR82210B/el unknown
- 1984-06-13 DD DD84264102A patent/DD218624A5/en not_active IP Right Cessation
- 1984-06-13 DE DE8484730062T patent/DE3468030D1/en not_active Expired
- 1984-06-14 HU HU842310A patent/HU191131B/en not_active IP Right Cessation
- 1984-06-14 AU AU29361/84A patent/AU572849B2/en not_active Ceased
- 1984-06-14 IE IE1484/84A patent/IE57620B1/en not_active IP Right Cessation
- 1984-06-14 PT PT78732A patent/PT78732B/en not_active IP Right Cessation
- 1984-06-14 NO NO842394A patent/NO160521C/en unknown
- 1984-06-15 NZ NZ208441A patent/NZ208441A/en unknown
- 1984-06-15 CA CA000456734A patent/CA1307784C/en not_active Expired - Lifetime
-
1989
- 1989-09-28 JP JP1250836A patent/JPH02167296A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| NO160521C (en) | 1989-04-26 |
| GR82210B (en) | 1984-12-13 |
| EP0129499B1 (en) | 1987-12-09 |
| EP0129499A2 (en) | 1984-12-27 |
| PT78732A (en) | 1985-01-01 |
| IL72085A (en) | 1987-09-16 |
| NO160521B (en) | 1989-01-16 |
| AU572849B2 (en) | 1988-05-19 |
| HUT36139A (en) | 1985-08-28 |
| IE57620B1 (en) | 1993-02-10 |
| NO842394L (en) | 1984-12-17 |
| FI842395A7 (en) | 1984-12-16 |
| DK288184D0 (en) | 1984-06-12 |
| FI78709C (en) | 1989-09-11 |
| DK166729B1 (en) | 1993-07-05 |
| ES533260A0 (en) | 1985-02-01 |
| PT78732B (en) | 1986-06-03 |
| DE3468030D1 (en) | 1988-01-21 |
| EP0129499A3 (en) | 1985-10-09 |
| DD218624A5 (en) | 1985-02-13 |
| JPH0369919B2 (en) | 1991-11-05 |
| FI78709B (en) | 1989-05-31 |
| AU2936184A (en) | 1984-12-20 |
| JPH02167296A (en) | 1990-06-27 |
| FI842395A0 (en) | 1984-06-13 |
| IL72085A0 (en) | 1984-10-31 |
| HU191131B (en) | 1987-01-28 |
| DK288184A (en) | 1984-12-16 |
| ES8502612A1 (en) | 1985-02-01 |
| NZ208441A (en) | 1988-01-08 |
| CA1307784C (en) | 1992-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8502612A1 (en) | 13-Alpha-alkyl gonanes, their preparation and pharmaceutical compositions containing them. | |
| CA1262357A (en) | N-hydroxyl protecting groups and process for the preparation of 3-acylamino-1-hydroxy-2-azetidinones | |
| HUT44041A (en) | Process for producing new diamino-androstane derivatives | |
| IE790233L (en) | Piperazine derivatives and intermediates in their¹preparation. | |
| KR870002124A (en) | Method for preparing tryptamine derivatives | |
| HUT49368A (en) | New process for producing 6-methylene derivatives of androsta-1,4-dien-3,17-dione | |
| IE792329L (en) | Thiazaheterocyclics and process for preparing pyrrolidine¹and piperidine derivatives. | |
| ES8404694A1 (en) | 14-Amino steroid derivatives, a process for the preparation thereof and method of use thereof | |
| AU3406684A (en) | Estrane and androstane derivatives | |
| HUT53628A (en) | Process for selective etherification | |
| HUT38951A (en) | Process for preparing pregnane derivatives | |
| EP0896961A4 (en) | PROCESS FOR THE MANUFACTURE OF 3-DIHALOBENZYL-2,4-QUINAZOLINEDIONE DERIVATIVES | |
| AU8236387A (en) | Improved keto-reduction of carbacycline intermediates | |
| CS345086A2 (en) | Zpusob vyroby 2 karboxypyrazin 4 oxidu | |
| JPS5729588A (en) | Preparation of thiazolidine compound | |
| KR870003114A (en) | Tetrahydroisoquinoline derivatives | |
| ATE1008T1 (en) | ISOMERIZATION OF 3-AZABI CYCLO(3.1.0)HEXANE DERIVATIVES. | |
| IE850305L (en) | Carbacyclins | |
| JPS56166179A (en) | Dibenzoxazepine derivative and its preparation | |
| JPS55139381A (en) | Spiroisochroman | |
| JPS56156263A (en) | Carbostyril derivative | |
| JPS5387370A (en) | Preparation of penicillamine derivative | |
| ES8507481A1 (en) | Thioamides, their preparation and their uses. | |
| DE58900971D1 (en) | METHOD FOR PRODUCING TETRAL IN DERIVATIVES AND NEW TETRAL IN DERIVATIVES. | |
| IE780770L (en) | Thiazolo-rifamycin sv derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |